CLC Drug Discovery Workbench is your new virtual lab bench. It gives you access to atomic level insights in protein-ligand interaction, and allows new ideas for improved binders to be quickly tested and visualized.The workbench empowers bench chemists as well as computational chemists to analyze and visualize protein targets and ligands binding to them. The intuitive and powerful interface is designed to communicate with all chemists, with no assumptions about their level of theoretical training. Medicinal chemists can visualize and model molecule interactions to work with ideas in a frictionless manner, thus fueling innovation.CLC Drug Discovery Workbench is part of the CLC bio Enterprise Platform with support for workflows, client-server setup, and command-line tools. Furthermore, like all other workbenches from CLC bio, the Drug Discovery Workbench runs on Mac OS X, Windows, and Linux platforms.Product sheetQuick Guide - Molecule visualizationsQuick Guide - Fast Track DockingQuick Guide - Hit to LeadQuick Guide - Virtual ScreeningQuick Guide - Protein Insights
For a diverse set of 85 high resolution protein-ligand complexes* relevant to the pharmaceutical or agrochemical industry, it is tested how many of the complexes can be reproduced in molecular docking with a ligand binding mode with RMSD of less than 2 Å.